Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NON-SMALL CELL LUNG CANCER (NSCLC), . Treffer: 50

2023

Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Mykoliuk, I; Taucher, E; Pichler, M; Smolle, J; Smolle-Juettner, FM The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
Cells. 2023; 12(3): Doi: 10.3390/cells12030480 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Maitz, K; Valadez-Cosmes, P; Santiso, A; Hasenoehrl, C; Brcic, L; Lindenmann, J; Kargl, J; Schicho, R Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells.
Front Immunol. 2022; 13:997115 Doi: 10.3389/fimmu.2022.997115 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Brcic, L; Savic, Prince, S [Predictive immunocytochemistry in non-small cell lung carcinoma].
PATHOLOGE. 2022; 43(3): 222-228. Doi: 10.1007/s00292-022-01066-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Feng, J; Li, Y; Wei, B; Guo, L; Li, W; Xia, Q; Zhao, C; Zheng, J; Zhao, J; Sun, R; Guo, Y; Brcic, L; Hakozaki, T; Ying, J; Ma, J Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.
Transl Lung Cancer Res. 2022; 11(4): 617-631. Doi: 10.21037/tlcr-22-202 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konjić, S; Valipour, A Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med. 2022; 11(14): Doi: 10.3390/jcm11144098 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zhang, H; Zhu, X; Friesen, TJ; Kwak, JW; Pisarenko, T; Mekvanich, S; Velasco, MA; Randolph, TW; Kargl, J; Houghton, AM Annexin A2/TLR2/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils.
J Clin Invest. 2022; 132(22): Doi: 10.1172/JCI153643 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Tufman, A; Swalduz, A; Lamberg, K; Hashemi, SMS; Huemer, F; Vikstrom, A; Wermke, M; Absenger, G; Addeo, A; Banerji, S; Calles, A; Clarke, S; Di Maio, M; Durand, A; Duruisseaux, M; Itchins, M; Kaaranien, OS; Krenn, F; Laack, E; de Langen, AJ; Mohorcic, K; Pall, G; Passaro, A; Prager, G; Rittmeyer, A; Rothenstein, J; Schumacher, M; Woll, E; Valipour, A Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
THER ADV MED ONCOL. 2021; 13: 17588359211019675 Doi: 10.1177/17588359211019675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kienzl, M; Hasenoehrl, C; Maitz, K; Sarsembayeva, A; Taschler, U; Valadez-Cosmes, P; Kindler, O; Ristic, D; Raftopoulou, S; Santiso, A; Bärnthaler, T; Brcic, L; Hahnefeld, L; Gurke, R; Thomas, D; Geisslinger, G; Kargl, J; Schicho, R Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer.
Oncoimmunology. 2021; 10(1): 1965319 Doi: 10.1080/2162402X.2021.1965319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Taucher, V; Lindenmann, J; Jost, PJ; Pichler, M Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer.
Cancers (Basel). 2021; 13(4): Doi: 10.3390/cancers13040699 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Taucher, V; Lindenmann, J; Pichler, M; Smolle-Juettner, FM Liquid biopsy in non-small cell lung cancer-current status and future outlook-a narrative review.
Transl Lung Cancer Res. 2021; 10(5): 2237-2251. Doi: 10.21037/tlcr-21-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tian, Y; Li, P; Xiao, Z; Zhou, J; Xue, X; Jiang, N; Peng, C; Wu, L; Tian, H; Popper, H; Poh, ME; Marcucci, F; Zhang, C; Zhao, X Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma.
TRANSL LUNG CANCER R. 2021; 10(2): 1007-1019. Doi: 10.21037/tlcr-21-145 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Valadez-Cosmes, P; Maitz, K; Kindler, O; Raftopoulou, S; Kienzl, M; Santiso, A; Mihalic, ZN; Brcic, L; Lindenmann, J; Fediuk, M; Pichler, M; Schicho, R; Houghton, AM; Heinemann, A; Kargl, J Identification of Novel Low-Density Neutrophil Markers Through Unbiased High-Dimensional Flow Cytometry Screening in Non-Small Cell Lung Cancer Patients.
Front Immunol. 2021; 12: 703846 Doi: 10.3389/fimmu.2021.703846 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wilke, L; Moustakis, C; Blanck, O; Albers, D; Albrecht, C; Avcu, Y; Boucenna, R; Buchauer, K; Etzelstorfer, T; Henkenberens, C; Jeller, D; Jurianz, K; Kornhuber, C; Kretschmer, M; Lotze, S; Meier, K; Pemler, P; Riegler, A; Röser, A; Schmidhalter, D; Spruijt, KH; Surber, G; Vallet, V; Wiehle, R; Willner, J; Winkler, P; Wittig, A; Guckenberger, M; Tanadini-Lang, S Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
Strahlenther Onkol. 2021; Doi: 10.1007/s00066-021-01799-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Lindenmann, J; Fink-Neuboeck, N; Taucher, V; Pichler, M; Posch, F; Brcic, L; Smolle, E; Koter, S; Smolle, J; Smolle-Juettner, FM Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score.
Cancers (Basel). 2020; 12(1): Doi: 10.3390/cancers12010152 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Munkhbaatar, E; Dietzen, M; Agrawal, D; Anton, M; Jesinghaus, M; Boxberg, M; Pfarr, N; Bidola, P; Uhrig, S; Höckendorf, U; Meinhardt, AL; Wahida, A; Heid, I; Braren, R; Mishra, R; Warth, A; Muley, T; Poh, PSP; Wang, X; Fröhling, S; Steiger, K; Slotta-Huspenina, J; van, Griensven, M; Pfeiffer, F; Lange, S; Rad, R; Spella, M; Stathopoulos, GT; Ruland, J; Bassermann, F; Weichert, W; Strasser, A; Branca, C; Heikenwalder, M; Swanton, C; McGranahan, N; Jost, PJ MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Nat Commun. 2020; 11(1):4527 Doi: 10.1038/s41467-020-18372-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Leithner, K; Olschewski, H Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations.
Thorac Cancer. 2020; 11(2):205-215 Doi: 10.1111/1759-7714.13246 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, HH; Olschewski, H; Leithner, K Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Mol Oncol. 2020; 14(11):2853-2867 Doi: 10.1002/1878-0261.12780 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

de Wit, S; Rossi, E; Weber, S; Tamminga, M; Manicone, M; Swennenhuis, JF; Groothuis-Oudshoorn, CGM; Vidotto, R; Facchinetti, A; Zeune, LL; Schuuring, E; Zamarchi, R; Hiltermann, TJN; Speicher, MR; Heitzer, E; Terstappen, LWMM; Groen, HJM Single tube liquid biopsy for advanced non-small cell lung cancer.
Int J Cancer. 2019; 144(12): 3127-3137. Doi: 10.1002/ijc.32056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kargl, J; Zhu, X; Zhang, H; Yang, GHY; Friesen, TJ; Shipley, M; Maeda, DY; Zebala, JA; McKay-Fleisch, J; Meredith, G; Mashadi-Hossein, A; Baik, C; Pierce, RH; Redman, MW; Thompson, JC; Albelda, SM; Bolouri, H; Houghton, AM Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC.
JCI Insight. 2019; 4(24): Doi: 10.1172/jci.insight.130850 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Pichler, M Non-Smoking-Associated Lung Cancer: A distinct Entity in Terms of Tumor Biology, Patient Characteristics and Impact of Hereditary Cancer Predisposition.
Cancers (Basel). 2019; 11(2): Doi: 10.3390/cancers11020204 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sutic, M; Motzek, A; Bubanovic, G; Linke, M; Sabol, I; Vugrek, O; Ozretic, P; Brcic, L; Seiwerth, S; Debeljak, Z; Jakovcevic, A; Janevski, Z; Stancic-Rokotov, D; Vukic-Dugac, A; Jakopovic, M; Samarzija, M; Zechner, U; Knezevic, J Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC)
TRANSL LUNG CANCER R. 2019; 8(6): 1000-+. Doi: 10.21037/tlcr.2019.12.08 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Veatch, JR; Jesernig, BL; Kargl, J; Fitzgibbon, M; Lee, SM; Baik, C; Martins, R; Houghton, AM; Riddell, SR Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.
CANCER IMMUNOL RES. 2019; 7(6): 910-922. Doi: 10.1158/2326-6066.CIR-18-0402 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Frille, A; Leithner, K; Olschewski, A; Olschewski, H; Wohlkönig, C; Hrzenjak, A No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Int J Oncol. 2018; 52(2): 518-526. Doi: 10.3892/ijo.2017.4225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Brcic, L; Lindenmann, J; Fink-Neuboeck, N; Gollowitsch, F; Stacher-Priehse, E; Asslaber, M; Gogg-Kamerer, M; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Sokolova, O; Naumann, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Eur J Cancer. 2018; 101(4):165-180 Doi: 10.1016/j.ejca.2018.07.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kriegshäuser, G; Enko, D; Novy, M; Reitmayr, A; Loidl, A; Halwachs-Baumann, G; Oberkanins, C EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.
Appl Immunohistochem Mol Morphol. 2018; 26(6):388-392 Doi: 10.1097/PAI.0000000000000439
Web of Science PubMed FullText FullText_MUG

 

Mark, NM; Kargl, J; Busch, SE; Yang, GHY; Metz, HE; Zhang, H; Hubbard, JJ; Pipavath, SNJ; Madtes, DK; Houghton, AM Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.
Am J Respir Crit Care Med. 2018; 197(3):325-336 Doi: 10.1164/rccm.201704-0795OC [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moll, HP; Pranz, K; Musteanu, M; Grabner, B; Hruschka, N; Mohrherr, J; Aigner, P; Stiedl, P; Brcic, L; Laszlo, V; Schramek, D; Moriggl, R; Eferl, R; Moldvay, J; Dezso, K; Lopez-Casas, PP; Stoiber, D; Hidalgo, M; Penninger, J; Sibilia, M; Győrffy, B; Barbacid, M; Dome, B; Popper, H; Casanova, E Afatinib restrains K-RAS-driven lung tumorigenesis.
Sci Transl Med. 2018; 10(446): Doi: 10.1126/scitranslmed.aao2301 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ryska, A; Berzinec, P; Brcic, L; Cufer, T; Dziadziuszko, R; Gottfried, M; Kovalszky, I; Olszewski, W; Oz, B; Plank, L; Timar, J NSCLC molecular testing in Central and Eastern European countries.
BMC Cancer. 2018; 18(1): 269-269. Doi: 10.1186/s12885-018-4023-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ryska, A; Buiga, R; Fakirova, A; Kern, I; Olszewski, W; Plank, L; Seiwerth, S; Toth, E; Zivka, E; Thallinger, C; Zielinski, C; Brcic, L Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
Oncologist. 2018; 23(12):e152-e158-e152-e158 Doi: 10.1634/theoncologist.2018-0008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Fadejeva, I; Olschewski, H; Hrzenjak, A MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.
Oncotarget. 2017; 8(70):115754-115773 Doi: 10.18632/oncotarget.22975 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mehta, AK; Hua, K; Whipple, W; Nguyen, MT; Liu, CT; Haybaeck, J; Weidhaas, J; Settleman, J; Singh, A Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS mutant mesenchymal-like NSCLC cells.
Sci Signal. 2017; 10(496): Doi: 10.1126/scisignal.aam6291 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wohlkoenig, C; Leithner, K; Olschewski, A; Olschewski, H; Hrzenjak, A TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α.
Lung Cancer. 2017; 111(3):15-22 Doi: 10.1016/j.lungcan.2017.06.013
Web of Science PubMed FullText FullText_MUG

 

2016

Leithner, K; Hirschmugl, B; Li, Y; Tang, B; Papp, R; Nagaraj, C; Stacher, E; Stiegler, P; Lindenmann, J; Olschewski, A; Olschewski, H; Hrzenjak, A TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers.
PLoS One. 2016; 11(6):e0157453-e0157453 Doi: 10.1371/journal.pone.0157453 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Grah, JJ; Katalinic, D; Juretic, A; Santek, F; Samarzija, M Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Tumori. 2014; 100(1):60-68 Doi: 10.1700/1430.15817
Web of Science PubMed FullText FullText_MUG

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Gallé, B; Guelly, C; Quehenberger, F; Stiegler, P; Smolle-Jüttner, FM; Philipsen, S; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.
BMC Cancer. 2014; 14(1):40-40 Doi: 10.1186/1471-2407-14-40 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pircher, A; Gamerith, G; Amann, A; Reinold, S; Popper, H; Gächter, A; Pall, G; Wöll, E; Jamnig, H; Gastl, G; Wolf, AM; Hilbe, W; Wolf, D Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Lung Cancer. 2014; 85(1): 81-87. Doi: 10.1016/j.lungcan.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

Pircher, A; Manzl, C; Fiegl, M; Popper, H; Pirker, R; Hilbe, W Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient.
Lung Cancer. 2014; 83(3): 408-410. Doi: 10.1016/j.lungcan.2013.12.007 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Posch, F; Setinek, U; Flores, RM; Bernhard, D; Hannigan, GE; Mueller, MR; Watzka, SB Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study.
Clin Transl Oncol. 2014; 16(5): 455-462. Doi: 10.1007/s12094-013-1101-6
Web of Science PubMed FullText FullText_MUG

 

2013

Olaussen, KA; Adam, J; Vanhecke, E; Vielh, P; Pirker, R; Friboulet, L; Popper, H; Robin, A; Commo, F; Thomale, J; Kayitalire, L; Filipits, M; Le Chevalier, T; André, F; Brambilla, E; Soria, JC PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Lung Cancer. 2013; 80(2):216-222 Doi: 10.1016/j.lungcan.2013.01.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Thunnissen, E; Kerr, KM; Herth, FJ; Lantuejoul, S; Papotti, M; Rintoul, RC; Rossi, G; Skov, BG; Weynand, B; Bubendorf, L; Katrien, G; Johansson, L; Lpez-Ros, F; Ninane, V; Olszewski, W; Popper, H; Jaume, S; Schnabel, P; Thiberville, L; Laenger, F The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
Lung Cancer. 2012; 76(1):1-18 Doi: 10.1016/j.lungcan.2011.10.017
Web of Science PubMed FullText FullText_MUG

 

2011

Kriegshäuser, G; Fabjani, G; Ziegler, B; Zöchbauer-Müller, S; End, A; Zeillinger, R Biochip-based detection of KRAS mutation in non-small cell lung cancer.
Int J Mol Sci. 2011; 12(12): 8530-8538. Doi: 10.3390/ijms12128530 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Watzka, SB; Posch, F; Hochmair, M; Setinek, U; Köstler, WJ; Müller, MR Resistance to EGFR targeting therapies in lung cancer.
Minerva Chir. 2011; 66(5): 483-494.
Web of Science PubMed

 

2010

Kriegshäuser, G; Auner, V; Zeillinger, R New and potential clinical applications of KRAS as a cancer biomarker.
Expert Opin Med Diagn. 2010; 4(5):383-395 Doi: 10.1517/17530059.2010.510512
PubMed FullText FullText_MUG

 

Pircher, A; Ploner, F; Popper, H; Hilbe, W Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients.
Lung Cancer. 2010; 69(3): 265-271. Doi: 10.1016/j.lungcan.2010.01.017
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Smolle-Juettner, FM; Maier, A; Lindenmann, J; Matzi, V; Neubock, N Resection in Stage I/II Non-Small Cell Lung Cancer
FRONT RADIAT THER ONCOL. 2010; 42: 71-77. Doi: 10.1159/000262462
Web of Science PubMed FullText FullText_MUG

 

2006

Pohl, G; Krajnik, G; Malayeri, R; Müller, RM; Klepetko, W; Eckersberger, F; Schäfer-Prokop, C; Pokrajac, B; Schmeikal, S; Maier, A; Ambrosch, G; Woltsche, M; Minar, W; Pirker, R Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
Lung Cancer. 2006; 54(1):63-67 Doi: 10.1016/j.lungcan.2006.05.027
Web of Science PubMed FullText FullText_MUG

 

2001

Sasaki, H; Lo, KM; Chen, LB; Auclair, D; Nakashima, Y; Moriyama, S; Fukai, I; Tam, C; Loda, M; Fujii, Y Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
Jpn J Cancer Res. 2001; 92(8): 869-873. Doi: 10.1111/j.1349-7006.2001.tb01174.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1997

Mayer, R; Smolle-Juettner, FM; Szolar, D; Stuecklschweiger, GF; Quehenberger, F; Friehs, G; Hackl, A Postoperative radiotherapy in radically resected non-small cell lung cancer.
Chest. 1997; 112(4):954-959 Doi: 10.1378/chest.112.4.954 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Smolle-Juettner, FM; Geyer, E; Kapp, KS; Ratzenhofer, B; Stuecklschweiger, G; Kaufmann, NB; Smolle, J; Pongratz, GM; Hackl, A; Friehs, G Evaluating intraoperative radiation therapy (IORT) and external beam radiation therapy (EBRT) in non-small cell lung cancer (NSCLC). Five years experience.
Eur J Cardiothorac Surg. 1994; 8(10):511-516 Doi: 10.1016/1010-7940(94)90067-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum